HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruokuo Han Selected Research

fisogatinib

1/2022BLU-554, A selective inhibitor of FGFR4, exhibits anti-tumour activity against gastric cancer in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruokuo Han Research Topics

Disease

3Neoplasms (Cancer)
03/2024 - 12/2020
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Stomach Neoplasms (Stomach Cancer)
01/2022
1Breast Neoplasms (Breast Cancer)
12/2020

Drug/Important Bio-Agent (IBA)

1GTP-Binding Proteins (G-Protein)IBA
03/2024
1fisogatinibIBA
01/2022
1Mitogen-Activated Protein KinasesIBA
01/2022
1Type 4 Fibroblast Growth Factor ReceptorIBA
01/2022
1Polysaccharides (Glycans)IBA
12/2020

Therapy/Procedure

1Immunotherapy
03/2024
1Therapeutics
12/2020